熱門詞： 進口電動溫度調節閥結構圖|進口電動溫度調節閥數據表進口電動高溫調節閥-德國進口電動高溫法蘭調節閥進口電動蒸汽調節閥-德國進口電動蒸汽調節閥
Agennix 美國Agennix
GPC Biotech AG (NASDAQ: GPCB) 和 Agennix 于2009年2月18號簽訂商業合并協議
Agennix AG is a biopharmaceutical company resulting from the combination of GPC Biotech AG and Agennix Incorporated in November 2009. We seek to have a meaningful impact on the length and quality of lives of cancer patients in areas of major unmet medical need by developing, and obtaining approval for, novel oncology therapies.
Our most advanced program is talactoferrin, an oral targeted therapy that is in Phase 3 clinical trials in non-small cell lung cancer. Additional clinical trials with talactoferrin in cancer indications are planned, including kidney cancer, for which Phase 2 data are available. Our other clinical development programs include RGB-286638, a multi-targeted kinase inhibitor in Phase 1 testing; the oral platinum-based compound satraplatin; and a topical gel form of talactoferrin for wound healing.
We are a transatlantic company with sites in Munich, Germany; Princeton, New Jersey and Houston, Texas.
知識產權侵權投訴：不生產任何產品所有產品均來自產品的生產廠商、代理商、經銷商，如有侵權請聯系：400-006-7520 ，我們會在第一時間處理
本網站所有產品與藥品無關
滬公網安備31011502016460號
